Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Erica E. Reed"'
Autor:
Elizabeth Rozycki, Ashley Weiner, Carlos Malvestutto, Nicholas E Kman, Mark Lustberg, Michael Dick, K. Joy Lehman, Ariane Schieber, Lynne Luca, Trisha A Jordan, Erica E Reed, James Allen, Jonathan Parsons, Courtney Nichols, Mark J Conroy
Publikováno v:
Hospital pharmacy. 57(5)
Background: Patients presenting for emergency department (ED) evaluation may be appropriate for treatment with monoclonal antibodies for mild to moderate COVID-19. While many sites have implemented infusion centers for these agents, EDs will continue
Autor:
Anthony T. Gerlach, Brittany R. Hoyte, Steven W. Cotten, Bruce A. Doepker, Claire V. Murphy, Erica E. Reed, Keaton S. Smetana, Lynn Wardlow
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.
Autor:
Jacob P. Counts, Jessica L. Elefritz, Erica E. Reed, Marilly Palettas, Connor Aossey, Julia J. Beatty
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 47:271-278
Publikováno v:
Open Forum Infectious Diseases. 9
Background Vancomycin (VAN) is an efficacious therapy against Streptococcus. VAN area under the curve to minimum inhibitory concentration (AUC/MIC) is the preferred monitoring strategy for serious methicillin-resistant S. aureus infections but is not
Autor:
Justin C Tossey, Kelci Coe, Zeinab El Boghdadly, Erica E Reed, Sherry N Williams, Jennifer Dela-Pena, Lynn Wardlow
Publikováno v:
Supportive Care in Cancer. 29:5057-5064
Bloodstream infections (BSI) are significant causes of morbidity and mortality in cancer patients. These patients often receive 10 to 14 days of intravenous (IV) antibiotics. The objective of this study was to compare the outcomes of cancer patients
Autor:
Jason W. Stull, Rachel C. Soltys, Dixie F. Mollenkopf, Thomas E. Wittum, Joshua B. Daniels, Dubraska Diaz-Campos, Jessica A. Shelby, Emily Feyes, Rikki L. Horne, Kurt B. Stevenson, Greg A. Ballash, Erica E Reed
Publikováno v:
Journal of the American Veterinary Medical Association. 258:170-178
Widespread use of antimicrobials in human and veterinary medicine drives the emergence and dissemination of resistant bacteria in human, animal, and environmental reservoirs. The AVMA and FDA Center for Veterinary Medicine have both taken public posi
Autor:
Kelci Coe, Zeinab El Boghdadly, Erica E Reed, Amy Parks Taylor, Lynn Wardlow, Kurt B. Stevenson
Publikováno v:
Hosp Pharm
Background: Various strategies aimed at limiting inappropriate antimicrobial use including antibiotic time out (ATO) have been proposed to combat the development of antimicrobial resistance, yet there are limited studies that have assessed the impact
Autor:
Claire V. Murphy, Erica E. Reed, Derrick D. Herman, BrookeAnne Magrum, Julia J. Beatty, Kurt B. Stevenson
Publikováno v:
Seminars in respiratory and critical care medicine. 43(1)
Increasing rates of infection and multidrug-resistant pathogens, along with a high use of antimicrobial therapy, make the intensive care unit (ICU) an ideal setting for implementing and supporting antimicrobial stewardship efforts. Overuse of antimic
Autor:
Jacob P, Counts, Jessica L, Elefritz, Erica E, Reed, Marilly, Palettas, Connor, Aossey, Julia J, Beatty
Publikováno v:
European journal of drug metabolism and pharmacokinetics. 47(2)
Optimal aminoglycoside dosing in critically ill patients represents a challenge for practitioners, especially in the medical intensive care unit (MICU). MICU patients exhibit altered pharmacokinetics due to pathophysiological changes the body undergo
Publikováno v:
Diagnostic Microbiology and Infectious Disease
The primary objectives were to determine the prevalence of and identify variables associated with respiratory bacterial co-infection in COVID-19 inpatients. Secondary outcomes included length of stay and in-hospital mortality. Eighty-two (11.2%) of 7